Ali Nili (A Nili)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Clinical Evaluation

Top Venues

Dermatologic therapy

Expert review of clinical immunology

Nature biotechnology

Reviews in medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Taha Rakhshandehroo, Shreya R Mantri, Heydar Moravej, Benjamin B V Louis, Ali Salehi Farid, Leila Munaretto, Kathryn Regan, Radia M M Khan, Alexandra Wolff, Zoe Farkash, Min Cong, Adrien Kuhnast, Ali Nili, Uk-Jae Lee, Harris H Allen, Lea Berland, Ester Simkova, Safak C Uslu, Soheil Tavakolpour, Jennifer E Rowley, Elisabeth Codet, Haneyeh Shahbazian, Jessika Baral, Jason Pyrdol, Caron A Jacobson, Omar Nadeem, Hadi T Nia, Kai W Wucherpfennig, Mohammad Rashidian
A CAR enhancer increases the activity and persistence of CAR T cells. Nature biotechnology (2024)
Elham Mazaherpour, Nika Kianfar, Shayan Dasdar, Mojtaba Sedaghat, Hassan Seyrafi, Kamran Balighi, Fatemeh Saberi, Ali Nili, Zeinab Farimani, Pedram Molhem Azar, Hamid Reza Mahmoudi, Dedee Frances Murrell, Maryam Danespazhooh
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patients. Dermatologic therapy (2022)
Hamid Reza Mahmoudi, Ali Nili, Ali Salehi Farid, Soheil Tavakolpour, Maryam Danespazhooh
Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption. The British journal of dermatology 185 (1) (2021)
Maryam Danespazhooh, Soheil Tavakolpour, Ali Salehi Farid, Mehrnoosh Ebadi, Ali Nili, Mohammad Rashidian, Hamid Reza Mahmoudi
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. International journal of dermatology 61 (1) (2021)
Ali Nili, Ali Salehi Farid, Masoud Asgari, Soheil Tavakolpour, Hamid Reza Mahmoudi, Maryam Danespazhooh
Current status and prospects for the diagnosis of pemphigus vulgaris. Expert review of clinical immunology 17 (8) (2021)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Ali Nili, Ali Salehi Farid, Maryam Danespazhooh, Mohammad Rashidian
Treatment of pemphigus patients in the COVID-19 era: A specific focus on rituximab. Dermatologic therapy 33 (6) (2020)
Ali Nili, Abolfazl Farbod, Afarin Neishabouri, Mohammad Mozafarihashjin, Soheil Tavakolpour, Hamidreza Mahmoudi
Remdesivir: A beacon of hope from Ebola virus disease to COVID-19. Reviews in medical virology 30 (6) (2020)
Borzouyeh Sadeghi, Ali Nili, Soheil Tavakolpour, Kamran Balighi, Maryam Danespazhooh, Hamid Reza Mahmoudi
Concomitant bullous pemphigoid and palmoplantar keratoderma: A report of three cases and review of literature. Dermatologic therapy 33 (6) (2020)
Ali Nili, Hamid Reza Mahmoudi, Nikta Heidari, Soheil Tavakolpour, Ali Salehi Farid, Kamran Balighi, Maryam Danespazhooh
Rituximab monotherapy in mild pemphigus. The Journal of dermatological treatment (2020)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Ali Salehi Farid, Ali Nili, Delnavaz Jan, Maryam Danespazhooh
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration. Dermatologic therapy 34 (1) (2020)
Mahsa Fallahi, Zahra Hallaji, Soheil Tavakolpour, Somayeh Niknam, Ali Salehi Farid, Ali Nili, Amir Teimourpour, Maryam Danespazhooh, Javad Rahmati, Shahriar Haddady Abianeh, Hamid Reza Mahmoudi
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial. Journal of cosmetic dermatology 20 (8) (2020)